These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 15217544)

  • 1. Update on progressive supranuclear palsy.
    Litvan I
    Curr Neurol Neurosci Rep; 2004 Jul; 4(4):296-302. PubMed ID: 15217544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive supranuclear palsy: where are we now?
    Burn DJ; Lees AJ
    Lancet Neurol; 2002 Oct; 1(6):359-69. PubMed ID: 12849397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnosis of progressive supranuclear palsy: current opinions and challenges.
    Ali F; Josephs K
    Expert Rev Neurother; 2018 Jul; 18(7):603-616. PubMed ID: 29902389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation.
    Stejskalova Z; Rohan Z; Rusina R; Tesar A; Kukal J; Kovacs GG; Bartos A; Matej R
    BMC Neurol; 2019 Mar; 19(1):42. PubMed ID: 30894142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive supranuclear palsy: a current review.
    Lubarsky M; Juncos JL
    Neurologist; 2008 Mar; 14(2):79-88. PubMed ID: 18332837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive Supranuclear Palsy: an Update.
    Armstrong MJ
    Curr Neurol Neurosci Rep; 2018 Feb; 18(3):12. PubMed ID: 29455271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive supranuclear palsy and multiple system atrophy: clinicopathological concepts and therapeutic challenges.
    Respondek G; Levin J; Höglinger GU
    Curr Opin Neurol; 2018 Aug; 31(4):448-454. PubMed ID: 29746401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches.
    Boxer AL; Yu JT; Golbe LI; Litvan I; Lang AE; Höglinger GU
    Lancet Neurol; 2017 Jul; 16(7):552-563. PubMed ID: 28653647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progressive supranuclear palsy; an unusual form of parkinsonism].
    Donker Kaat L; Boon AJ; Heutink P; van Swieten JC
    Ned Tijdschr Geneeskd; 2004 Mar; 148(11):519-23. PubMed ID: 15054950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.
    Liscic RM; Srulijes K; Gröger A; Maetzler W; Berg D
    Acta Neurol Scand; 2013 May; 127(5):362-70. PubMed ID: 23406296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management of progressive supranuclear palsy.
    Litvan I
    Semin Neurol; 2001; 21(1):41-8. PubMed ID: 11346024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and genetic aspects of progressive supranuclear palsy.
    Litvan I; Hutton M
    J Geriatr Psychiatry Neurol; 1998; 11(2):107-14. PubMed ID: 9877531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progressive supranuclear palsy: what's new?].
    Levy R
    Geriatr Psychol Neuropsychiatr Vieil; 2011 Jun; 9(2):191-201. PubMed ID: 21690028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on epidemiological aspects of progressive supranuclear palsy.
    Litvan I
    Mov Disord; 2003 Sep; 18 Suppl 6():S43-50. PubMed ID: 14502655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive supranuclear palsy.
    Mazorra L; Cadogan MP
    J Gerontol Nurs; 2012 Mar; 38(3):8-11. PubMed ID: 22329395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive supranuclear palsy and corticobasal degeneration: Diagnostic challenges and clinicopathological considerations.
    Eusebio A; Koric L; Félician O; Guedj E; Ceccaldi M; Azulay JP
    Rev Neurol (Paris); 2016; 172(8-9):488-502. PubMed ID: 27561438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caribbean parkinsonism and other atypical parkinsonian disorders.
    Tolosa E; Calandrella D; Gallardo M
    Parkinsonism Relat Disord; 2004 May; 10 Suppl 1():S19-26. PubMed ID: 15109583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinicopathological study of vascular progressive supranuclear palsy: a multi-infarct disorder presenting as progressive supranuclear palsy.
    Josephs KA; Ishizawa T; Tsuboi Y; Cookson N; Dickson DW
    Arch Neurol; 2002 Oct; 59(10):1597-601. PubMed ID: 12374498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive supranuclear palsy.
    Esper CD; Weiner WJ; Factor SA
    Rev Neurol Dis; 2007; 4(4):209-16. PubMed ID: 18195676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of restless legs syndrome in progressive supranuclear palsy.
    Moccia M; Picillo M; Erro R; Allocca R; Barone P; Vitale C
    J Neurol Sci; 2015 Mar; 350(1-2):103-4. PubMed ID: 25697711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.